0.00Open3.50Pre Close0 Volume596 Open Interest5.00Strike Price0.00Turnover0.00%IV-638.92%PremiumJan 17, 2025Expiry Date4.80Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.04Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Syros Pharmaceuticals Stock Discussion
👀
I'm wondering if Oxford Finance will demand immediate payment on the loan or if they will give some support by negotiating the loan? I don't know much. How likely are the odds on these 2?
Will the share price go to zero?
Syros Announces Topline Data From Select-Mds-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome With Rara Gene Overexpression! Did not meet endpoint!
No comment yet